Redirecting full-length FLT1 expression towards its soluble isoform by targeting alternative polyadenylation promotes postischaemic angiogenesis
Cardiovascular Research

Abstract
Vascular endothelial growth factors (VEGFs) and their endothelial tyrosine kinase receptors are crucial mediators of vasculogenesis and angiogenesis, with FLT1 (VEGFR1) acting as a decoy receptor for VEGFs. Alternative polyadenylation (APA) of Flt1 transcripts produces a truncated mRNA transcript encoding soluble (s) FLT1, which contains only the extracellular ligand-binding domain. The relative roles of full-length (fl) FLT1 and sFLT1 in angiogenesis are incompletely understood. Alternative polyadenylation is an important post-transcriptional mechanism of gene regulation that is increasingly recognized to affect the expression of many genes related to cardiovascular diseases. However, there are no
We here generated mice by introducing silent mutations into the
Our findings show that APA can be effectively targeted to modulate FLT1 isoform expression
Contributors

Maja Bundalo
Author

Sandra Vorlova
Author

Jessica Ulrich
Author

Giuseppe Rizzo
Author

Elke Butt
Author

Hendrik Bartolomaeus
Author

Hla Ali
Author

Ruggero Barbieri
Author

Leon Richter
Author

Leonie Höna
Author

Manuel Egg
Author

Julian Bock
Author

Sarah Schäfer
Author

Núria Amézaga Solé
Author

Annabelle Rosa
Author

Clément Cochain
Author

Andreas Beilhack
Author

Wolfgang Kastenmüller
Author

Erik Henke
Author

Boris V Skryabin
Author

Timofey S Rozhdestvensky
Author

Moritz Wildgruber
Author

Kristina Lorenz
Author

Michaela Kuhn
Author

Alma Zernecke
Author
You may be interested in




